66 related articles for article (PubMed ID: 34517553)
41. Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer.
Ma YS; Hou LK; Yao SH; Liu JB; Yu XC; Shi Y; Yang XL; Wu W; Wu CY; Jiang GX; Fu D
Mol Ther Oncolytics; 2021 Sep; 22():326-335. PubMed ID: 34553022
[TBL] [Abstract][Full Text] [Related]
42. A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer.
Li J; Tong Y; Wang Z; Liu Y; Dai X; Zhu Y
J Oncol; 2021; 2021():7404927. PubMed ID: 34539785
[TBL] [Abstract][Full Text] [Related]
43. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
44. Determination of a six-gene prognostic model for cervical cancer based on WGCNA combined with LASSO and Cox-PH analysis.
Li S; Han F; Qi N; Wen L; Li J; Feng C; Wang Q
World J Surg Oncol; 2021 Sep; 19(1):277. PubMed ID: 34530829
[TBL] [Abstract][Full Text] [Related]
45. Screening and evaluation of the role of immune genes of brain metastasis in lung adenocarcinoma progression based on the TCGA and GEO databases.
Chen C; Guo Q; Tang Y; Qu W; Zuo J; Ke X; Song Y
J Thorac Dis; 2021 Aug; 13(8):5016-5034. PubMed ID: 34527340
[TBL] [Abstract][Full Text] [Related]
46. Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis.
Xu J; Zhang Y; Liu C; Yan P; Yang Z
Int J Med Sci; 2021; 18(15):3556-3564. PubMed ID: 34522182
[No Abstract] [Full Text] [Related]
47. Cross-talk and clinical value of m[superscript 6]A regulatory gene in bladder cancer.
Zhou BZ; Luo Q; Zhang Y
BMC Urol; 2021 Sep; 21(1):127. PubMed ID: 34521394
[TBL] [Abstract][Full Text] [Related]
48. m
Demircan T; Yavuz M; Akgül S
OMICS; 2021 Oct; 25(10):660-678. PubMed ID: 34520276
[TBL] [Abstract][Full Text] [Related]
49. Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma.
Zhang D; Zhang D; Wang C; Yang X; Zhang R; Li Q; Xiong Y
Eur J Cancer Prev; 2022 Jul; 31(4):354-362. PubMed ID: 34519693
[TBL] [Abstract][Full Text] [Related]
50. A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia.
Gong H; Li H; Yang Q; Zhang G; Liu H; Ma Z; Peng H; Nie L; Xiao X; Liu J
Biomed Res Int; 2022; 2022():5646275. PubMed ID: 35845961
[TBL] [Abstract][Full Text] [Related]
51. Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.
Weng C; Wang L; Liu G; Guan M; Lu L
Front Oncol; 2021; 11():763027. PubMed ID: 34868980
[TBL] [Abstract][Full Text] [Related]
52. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
[TBL] [Abstract][Full Text] [Related]
53. Insights from a Computational-Based Approach for Analyzing Autophagy Genes across Human Cancers.
Murillo Carrasco AG; Giovanini G; Ramos AF; Chammas R; Bustos SO
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628602
[TBL] [Abstract][Full Text] [Related]
54. Construction of a prognostic model for lung squamous cell carcinoma based on seven N6-methylandenosine-related autophagy genes.
Yu X; Liu J; Xie R; Chang M; Xu B; Zhu Y; Xie Y; Yang S
Math Biosci Eng; 2021 Aug; 18(5):6709-6723. PubMed ID: 34517553
[TBL] [Abstract][Full Text] [Related]
55. Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes.
Jia E; Ren N; Guo B; Cui Z; Zhang B; Xue J
World J Surg Oncol; 2022 Feb; 20(1):59. PubMed ID: 35220962
[TBL] [Abstract][Full Text] [Related]
56. The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma.
Huang H; Wu W; Lu Y; Pan X
J Thorac Dis; 2022 Oct; 14(10):4055-4072. PubMed ID: 36389308
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
